Aquestive Therapeutics, Inc.
AQST· Nasdaq
AQSTAquestive Therapeutics, Inc.
Filed Nov 6, 2018 · 10-Q · 37 days after period end · 0001140361-18-042522
| Metric | Q3 2018 | Q3 2017 |
|---|---|---|
| Revenue | $13.27M | $27.15M |
| Net Income | -$15.04M | $8.45M |
| EPS Diluted | -$0.64 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aquestive Therapeutics, Inc. · CIK 1398733 · Engraved from SEC EDGAR
ended Sep 30, 2018 · filed Nov 6, 2018 · 37 d after period end
